Illumina, Inc. (NASDAQ: ILMN) announced new customer breakthroughs in oncology powered by Illumina's spatial transcriptomics, ...

Priya Hays, Hays Documentation Specialists, LLC, discusses biomarker discovery through artificial intelligence and ...

Ahead of AGBT, Ultima Genomics launched its UG200 series touting smaller footprint, faster runtime, higher output, and lower pricing.

The fate and physiology of individual cells are controlled by proteins. Yet, the ability to quantitatively analyze proteins in single cells has remained limited. Seeking to overcome this barrier, ...

The brain cancer glioblastoma (GBM) is characterized by the presence of cells that can mimic human neurons, even growing axons and making active connections with healthy brain neurons. This cancer ...

IRB Barcelona has launched Spain’s first fully integrated spatial omics platform, allowing researchers to capture cells' ...

A review of 471 omics publications on pituitary neuroendocrine tumors has resulted in a curated catalog of publicly available datasets, including methods and clinical annotations.

Immuto CEO Faraz Choudhury spoke with Pharmaceutical Executive about his company’s work with focusing on Surface Protein Conformations (SPCs) for target discovery. According to him, traditional target ...

Spatial proteomics is a spatial biology method that helps study the spatial distribution of the proteins within cells and tissues. The subcellular localization of proteins is intrinsic to cellular ...

This eBook cuts through the complexity of spatial techniques, featuring a series of inteveiws with pioneers in the field, and peer-reviewed research from the Taylor & Francis journal portfolio. This ...

Advances in 3D spatial multiomics are changing how researchers study tissue architecture. We spoke with Stellaromics' CEO, Dr. Todd Dickinson, to learn how this approach preserves structure and ...